Unter den Marken unserer mehr als 25 Partner sticht TargetMol hervor
We have reached an agreement with TargetMol: CymitQuimica clients will benefit for a 20% discount on all TargetMol products until the end of the year.On our website you can find the products offered by this partner, which has become one of the world's most recognised compound libraries and small molecule inhibitors supplier. TargetMol offers approximately 120 compound libraries and a wide range of chemical products and kits for life sciences.
Endet am 31. Dez.( 8 verbleibende Tage )
HPK1-IN-33
CAS:HPK1-IN-33 inhibits HPK1 with 1.7 nM potency, reduces IL-2 in Jurkat cells with 286 nM EC50, and is less effective in HPK1 KO cells.Formel:C18H16ClFN6Farbe und Form:SolidMolekulargewicht:370.81BAY1125976
CAS:<p>BAY1125976 is an allosteric inhibitor of Akt1 and Akt2 (IC50s of 5.2 and 18 nM, respectively, in a time-resolved FRET assay)</p>Formel:C23H21N5OReinheit:99.28% - ≥98%Farbe und Form:SolidMolekulargewicht:383.45PI3K-IN-36
CAS:PI3K-IN-36 is a potent inhibitor of PI3K, suitable for research applications in follicular lymphoma (FL).Formel:C30H36F2N8OFarbe und Form:SolidMolekulargewicht:562.66USP22-IN-1
CAS:<p>USP22-IN-1 is a ubiquitin-specific peptidase 22 (USP22) inhibitor that can be used to treat proliferative diseases or cancer.</p>Formel:C22H18N4Reinheit:98.2%Farbe und Form:SolidMolekulargewicht:338.41SLU-PP-915
CAS:SLU-PP-915, ERR agonist, EC50 ~400 nM for ERRα/β/γ, may aid oxidative metabolism & heart health.Formel:C17H13BFNO3SFarbe und Form:SolidMolekulargewicht:341.16EGFR-IN-69
CAS:EGFR-IN-69: Potent EGFR inhibitor for NSCLC research; IC50: 4.3-25.6 nM against various EGFR mutations.Formel:C31H37Cl2N7O3SFarbe und Form:SolidMolekulargewicht:658.64EGFR-IN-70
EGFR-IN-70: potent EGFR inhibitor, IC50 of 23.6 nM (LR/TM/CS), 307.5 nM (WT), anti-proliferative, inhibits EGFR phosphorylation, for cancer research.Formel:C31H36ClN5O5SFarbe und Form:SolidMolekulargewicht:626.17BMS-986339
CAS:BMS-986339: oral, potent FXR agonist; binds to His298/ASN287; for PBC, PSC, NASH, anti-fibrosis research.Formel:C35H41F4N3O4Farbe und Form:SolidMolekulargewicht:643.71LabMol-301
CAS:LabMol-301 blocks NS5 RdRp/NS2B-NS3pro (IC50: 0.8/7.4µM), protects cells from ZIKV death.Formel:C18H16N6Farbe und Form:SolidMolekulargewicht:316.36LY2828360
CAS:LY2828360: CB2 agonist, Ki=40.3 nM; biases CB2 over CB1 with EC50s of 20.1 nM and >100 μM.Formel:C22H27ClN6OReinheit:98.45% - 99.51%Farbe und Form:SolidMolekulargewicht:426.94HadAB-IN-1
CAS:HadAB-IN-1: potent TB research chemical; IC50 = 0.03μM; inhibits HadAB, affecting Mtb mycolic acid synthesis.Formel:C19H17BrClN3O3SFarbe und Form:SolidMolekulargewicht:482.78CDK7-IN-20
CDK7-IN-20: potent, irreversible CDK7 inhibitor, IC50 of 4nM, 206x selectivity vs. other CDKs, potential for ADPKD study.Formel:C30H26N6O3Farbe und Form:SolidMolekulargewicht:518.57SOS1-IN-15
CAS:<p>SOS1-IN-15 is an orally active and potent SOS1 inhibitor with potential antitumor activity.SOS1-IN-15 is used in the study of colon cancer.</p>Formel:C28H27F3N6O2Reinheit:98.32%Farbe und Form:SolidMolekulargewicht:536.548EGFR-IN-73
CAS:EGFR-IN-73 (Compound 3f) effectively inhibits the prevalent EGFR mutation, EGFR Del19, exhibiting an IC50 value of 119 nM [1].Formel:C19H17ClFN3O4Reinheit:98%Farbe und Form:SolidMolekulargewicht:405.81FUBP1-IN-2
CAS:FUBP1-IN-2 hinders FUBP1, affects c-Myc and p21 expression, and depletes polyamines.Formel:C26H26ClN3O4Farbe und Form:SolidMolekulargewicht:479.96HDAC-IN-49
<p>HDAC-IN-49: potent, broad HDAC inhibitor; IC50s: 10-1880 nM for HDAC1-6; strong anti-leukemic, low toxicity to healthy cells.</p>Formel:C26H27FN4O4Farbe und Form:SolidMolekulargewicht:478.52CU-CPT-9a
CAS:<p>CU-CPT-9a is a potent TLR8 inhibitor (IC50 : 0.5 nM), that suppresses TLR8-mediated proinflammatory signaling in various cell lines and human primary cells-</p>Formel:C17H15NO2Reinheit:99.01%Farbe und Form:SolidMolekulargewicht:265.31EGFR-IN-74
EGFR-IN-74 is a potent inhibitor targeting EGFR, specifically effective against the L858R/T790M mutations, exhibiting an IC50 value of 138 nM.Formel:C32H28BrF3N6O4SFarbe und Form:SolidMolekulargewicht:729.57FOXM1-IN-1
FOXM1-IN-1: Potent inhibitor of FOXM1, IC50=2.65µM, hinders cell growth & lowers FOXM1, PLK1, CDC25B levels.Formel:C23H30ClNO3Farbe und Form:SolidMolekulargewicht:403.94MMP-1-IN-1
MMP-1-IN-1 is a highly potent MMP-1 inhibitor with an IC 50 of 0.034 μM .Formel:C14H17ClN2O3Farbe und Form:SolidMolekulargewicht:296.75LRRK2-IN-7
CAS:LRRK2-IN-7: potent, selective CNS-active LRRK2 inhibitor, IC50 0.9 nM, >1000x selectivity vs kinases/channels/CYPs.Formel:C24H26N6OReinheit:99.26%Farbe und Form:SolidMolekulargewicht:414.5hCAII-IN-9
CAS:<p>hCAII-IN-9 inhibits hCA II/IX/XII with IC50s of 1.18, 0.17, 2.99 μM; not BBB permeable.</p>Formel:C15H16ClN3O5S2Reinheit:98.63%Farbe und Form:SolidMolekulargewicht:417.89EGFR-IN-75
EGFR-IN-75 inhibits EGFR WT/T790M; IC50s: 0.28/5.02 μM. It has anticancer and antioxidant effects.Formel:C10H6N6S2Farbe und Form:SolidMolekulargewicht:274.32HDAC-IN-50
CAS:HDAC-IN-50, a potent FGFR/HDAC inhibitor (IC50: 0.18-13 nM), induces apoptosis, cell cycle arrest, and shows anti-tumor activity.Formel:C31H41N7O4Farbe und Form:SolidMolekulargewicht:575.7Elimusertib
CAS:Elimusertib (BAY-1895344) is a potent, highly selective and orally available ATR inhibitor with an IC50 of 7 nM.Elimusertib shows potent anti-tumor efficacy inFormel:C20H21N7OReinheit:98.72% - 99.84%Farbe und Form:SolidMolekulargewicht:375.43NSC 295642
CAS:<p>NSC 295642: phosphatase inhibitor, boosts phospho-Erk in cells, aids cancer research.</p>Formel:C15H14ClCuN3S2Farbe und Form:SolidMolekulargewicht:399.42HDAC-IN-51
HDAC-IN-51 is an HDAC inhibitor.Formel:C27H24N4O2Reinheit:98.85%Farbe und Form:SolidMolekulargewicht:436.51BSJ-04-122
CAS:BSJ-04-122: MKK4/7 inhibitor with IC50s of 4 nM & 181 nM, used in cancer research.Formel:C15H12ClN5OReinheit:98.09%Farbe und Form:SolidMolekulargewicht:313.74SMYD3-IN-2
SMYD3-IN-2, a cancer research chemical, inhibits SMYD3 (IC50 0.81 μM) and BGC823 (IC50 0.75 μM), inducing fatal autophagy in gastric cancer.Formel:C26H21BrN2O4Farbe und Form:SolidMolekulargewicht:505.36BChE-IN-15
<p>BChE-IN-15 is a compound characterized as a pseudo-irreversible, covalent inhibitor of butyrylcholinesterase (BChE), demonstrating potent activity with an</p>Formel:C22H33N3O2Farbe und Form:SolidMolekulargewicht:371.52PRMT6-IN-3
CAS:PRMT6-IN-3 is a selective PRMT6 inhibitor with an IC50 value of 192 nM.PRMT6-IN-3 has anticancer activity and induces apoptosis in cancer cells.Formel:C19H26N4O2SReinheit:98.12%Farbe und Form:SolidMolekulargewicht:374.5HPK1-IN-31
HPK1-IN-31 inhibitor with an IC 50 value of 0.8 nM. HPK1-IN-31 has anti-tumour activity and has great potential for immunotherapy .Formel:C30H33N7O3Farbe und Form:SolidMolekulargewicht:539.63BuChE-IN-7
<p>BuChE-IN-7: selective hBuChe & eqBuChe inhibitor, IC50s 40/80 nM, boosts cognition & memory, and penetrates blood-brain barrier.</p>Formel:C25H34N2O2Farbe und Form:SolidMolekulargewicht:394.55RK-0133114
RK-0133114, R-enantiomer of RK-701, is a G9a inhibitor (IC50 = 3.7 μM) for SCD research.Formel:C26H30N4O3Farbe und Form:SolidMolekulargewicht:446.54Ficonalkib
CAS:Ficonalkib is a potent antineoplastic agent that inhibits the Anaplastic Lymphoma Kinase (ALK) tyrosine kinase receptor.Formel:C29H39N7O3SFarbe und Form:SolidMolekulargewicht:565.737-Methylguanosine
CAS:7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor (IC50 : 87.8 ± 7.5 μM).Formel:C11H16N5O5Reinheit:98.11%Farbe und Form:SolidMolekulargewicht:298.28Fulzerasib
CAS:<p>Fulzerasib is an orally active KRAS G12C inhibitor that covalently binds to cysteine residue on the protein, thereby inhibiting the growth of KRAS G12C mutant</p>Formel:C32H30ClFN6O4Reinheit:98.04%Farbe und Form:SolidMolekulargewicht:617.07LONP1-IN-2
CAS:LONP1-IN-2: Potent LONP1 inhibitor, IC50=0.187μM; weak on 20S proteasome (>10μM); for cancer research.Formel:C16H27BN4O4Farbe und Form:SolidMolekulargewicht:350.22DOCK2-IN-1
CAS:<p>DOCK2-IN-1, a CPYPP analogue, inhibits DOCK2 (IC50=19.1μM), reversibly binds DHR-2, and suppresses lymphocyte chemotaxis and T cell activation.</p>Formel:C16H11ClN2O2Farbe und Form:SolidMolekulargewicht:298.72EAPB 02303
CAS:<p>EAPB 02303, a microtubule inhibitor, induces mitotic arrest, spindle impairment, apoptosis, and has antitumor effects, enhancing Paclitaxel.</p>Formel:C17H14N4O2Farbe und Form:SolidMolekulargewicht:306.32RGB-286638
CAS:RGB-286638 inhibits multiple CDKs and GSK-3β, TAK1, Jak2, MEK1 with IC50s as low as 1-54 nM.Formel:C29H37Cl2N7O4Farbe und Form:SolidMolekulargewicht:618.55Piperazine
CAS:<p>Piperazine (1,4-Diazacyclohexane), a gamma-aminobutyric acid (GABA) agonist, serves as a crucial building block and core component in a wide range of marketed drugs known for their varied pharmacological activities.</p>Formel:C4H10N2Farbe und Form:SolidMolekulargewicht:86.14Nifuroxime
CAS:Nifuroxime, an anti-infective agent, is utilized in researching fungal infections.Formel:C5H4N2O4Farbe und Form:SolidMolekulargewicht:156.1Yadanzigan
CAS:<p>Yadanzigan(YDZG),a specific NLRP3 inhibitor, attenuates the NF-κB pathway and reactive oxygen species generation, while enhancing TRIM31, anti-inflammatory.</p>Formel:C26H38O14Reinheit:99.98%Farbe und Form:SolidMolekulargewicht:574.57Tozadenant
CAS:Tozadenant (SYN115) is an adenosine A2A receptor antagonist(Ki of 11.5 nM and 6 nM on human and rhesus,respectively)Formel:C19H26N4O4SReinheit:98%Farbe und Form:SolidMolekulargewicht:406.5Stigmane B
<p>Stigmane B activates Nrf2, decreases apoptosis and ROS, boosts antioxidants, and is neuroprotective.</p>Formel:C21H30O4Farbe und Form:SolidMolekulargewicht:346.46BChE-IN-11
CAS:BChE-IN-11: potent, selective, non-competitive BChE inhibitor; IC50=2.1μM; used in AD research.Formel:C22H18O4Farbe und Form:SolidMolekulargewicht:346.38Praelolide
Praelolide activates Nrf2, hinders osteoclastogenesis/ROS, binds Keap1 noncovalently, may aid bone disease research.Formel:C28H35ClO12Farbe und Form:SolidMolekulargewicht:599.02Wikstrol A
CAS:Wikstrol A: antifungal, anti-mitotic, anti-HIV agent with various IC50/MDC values (67.8-131 µM) and deforms P. oryzae mycelia.Formel:C30H22O10Farbe und Form:SolidMolekulargewicht:542.49Laburnetin
CAS:Laburnetin: an isoflavone antibacterial, combats fungi/S. vesicarium, boosts MRSA methicillin susceptibility, used in pest control.Formel:C20H18O6Farbe und Form:SolidMolekulargewicht:354.35Olamkicept
CAS:Olamkicept (FE-301) is a soluble gp130-Fc-fusion protein that inhibits interleukin 6 (IL-6) trans signaling.Reinheit:98.2% (SDS-PAGE); 98.8% (SEC-HPLC) - 99.3% (SDS-PAGE); 97.6% (SEC-HPLC)Farbe und Form:LiquidMBP146-78
CAS:<p>MBP146-78 is a potent and selective cGMP inhibitor dependent protein kinases.</p>Formel:C21H22FN3Reinheit:99.33%Farbe und Form:SolidMolekulargewicht:335.42Notum-IN-1
CAS:Notum-IN-1 is an orally administered, selective, and brain-penetrating compound that acts as an inhibitor of Notum.Formel:C9H7Cl2N3OFarbe und Form:SolidMolekulargewicht:244.08RX 801077
CAS:RX 801077 is a selective I2R agonist, Ki of 70.1 nM, with anti-inflammatory and neuroprotective properties for TBI research.Formel:C11H10N2OFarbe und Form:SolidMolekulargewicht:186.21PD 168568
CAS:PD 168568: Oral DRD4 antagonist, selective over D2/D3, K_i - 8.8 nM. Used in GBM research.Formel:C22H27N3OFarbe und Form:SolidMolekulargewicht:349.47Gepefrine
CAS:Gepefrine为具口服活性的升压剂及拟交感神经作用剂，能有效改善动脉压早期直立性失调。Formel:C9H13NOFarbe und Form:SolidMolekulargewicht:151.21Crisnatol
CAS:<p>Crisnatol (BWA770U) is an oral anticancer DNA intercalator, toxic to breast cancer cells, not skin fibroblasts.</p>Formel:C23H23NO2Farbe und Form:SolidMolekulargewicht:345.43Epitizide
CAS:Epitizide, a benzothiadiazine, commonly found in combination Triamterene , is used to produce diuresis [1] .Formel:C10H11ClF3N3O4S3Farbe und Form:SolidMolekulargewicht:425.86Theliatinib
CAS:<p>Theliatinib: potent, selective EGFR inhibitor, anti-tumor; Ki=0.05 nM (EGFR), IC50=3 nM (EGFR), 22 nM (T790M/L858R).</p>Formel:C25H26N6O2Reinheit:99.67%Farbe und Form:SolidMolekulargewicht:442.51RO5461111
CAS:RO5461111: Oral Cathepsin S inhibitor, IC50 of 0.4 nM (human) & 0.5 nM (mouse), reduces T/B cell activation, treats lung inflammation & lupus nephritis.Formel:C27H24F6N4O4SFarbe und Form:SolidMolekulargewicht:614.56CASK-IN-1
CAS:CASK-IN-1 is a highly potent and selective CASK inhibitor with a K d value of 0.022 μM.Formel:C24H30Br2N6O3Farbe und Form:SolidMolekulargewicht:610.34LDHA-IN-5
CAS:LDHA-IN-5 is a novel and potent inhibitor targeting both glycolate oxidase (GO) and lactate dehydrogenase A (LDHA), designed for the treatment of primaryFormel:C27H22FN7O6S3Farbe und Form:SolidMolekulargewicht:655.7NS5A-IN-3
CAS:<p>NS5A-IN-3 is a potent NS5A inhibitor with high efficacy against HCV 1b, good activity on 3a, and strong metabolic stability; superior to daclatasvir.</p>Formel:C44H44N6O8Reinheit:98%Farbe und Form:SolidMolekulargewicht:784.86AMPK-IN-1
CAS:AMPK-IN-1 is an activator of the AMP-activated protein kinase (AMPK) enzyme, specifically targeting the α2β2γ1 isoform with an EC50 of 551 nM.Formel:C24H18ClN3O3Farbe und Form:SolidMolekulargewicht:431.87OTS193320
CAS:OTS193320, an imidazo[1,2-a]pyridine, inhibits SUV39H2, reduces H3K9me3, and induces apoptosis in breast cancer; enhances DOX effects.Formel:C28H30ClN5O4Farbe und Form:SolidMolekulargewicht:536.02SH-BC-893
CAS:SH-BC-893: Oral anti-cancer sphingolipid analog, prevents ceramide-related mitochondrial issues, and tackles diet-related obesity.Formel:C19H32ClNOFarbe und Form:SolidMolekulargewicht:325.92Artonin E
CAS:Artonin E, a prenylated flavonoid, induces apoptosis and S-phase arrest, disrupting the mitochondrial pathway for cancer research.Formel:C25H24O7Farbe und Form:SolidMolekulargewicht:436.45Mps1-IN-4
CAS:Mps1-IN-4 is a compound that selectively inhibits Monopolar spindle 1 (Mps1), exhibiting antiproliferative properties useful in cancer research.Formel:C26H31F3N6O2Farbe und Form:SolidMolekulargewicht:516.56BCI-215
CAS:<p>BCI-215 causes selective cancer cell cytotoxicity in part through non-redox-mediated activation of MAPK signaling</p>Formel:C22H22BrNOReinheit:99.812%Farbe und Form:SolidMolekulargewicht:396.32UT-B-IN-1
CAS:<p>UT-B-IN-1: reversible UT-B inhibitor, IC50: 10 nM (human), 25 nM (mouse), low toxicity, diuretic research tool.</p>Formel:C20H17N5O2S3Farbe und Form:SolidMolekulargewicht:455.58RR-RJW100
RR-RJW100: potent LRH-1 & SF-1 agonist; studies metabolic disorders, diabetes, liver disease, IBD.Formel:C28H34OFarbe und Form:SolidMolekulargewicht:386.57Ciramadol
CAS:Ciramadol (WY 15705) is a potent analgesic with dual narcotic effects, used in postoperative pain research.Formel:C15H23NO2Farbe und Form:SolidMolekulargewicht:249.35USP7-797
CAS:USP7-797 is a selective non-covalent active site USP7 inhibitor, inhibiting USP7 and ubiquitin binding, with anti-tumor, oral and high efficiency properties.Formel:C27H28ClN3O3SReinheit:95.90%Farbe und Form:SolidMolekulargewicht:510.05GPX4-IN-2
CAS:GPX4-IN-2 is a potent inhibitor of GPX4, exhibiting antiproliferative activity. It holds potential for cancer research applications.Formel:C30H40N2OFarbe und Form:SolidMolekulargewicht:444.65gTPA2-OMe
gTPA2-OMe is a potential hole transport layer candidate for perovskite solar cells (PSCs).Formel:C32H33N7O2Farbe und Form:SolidMolekulargewicht:547.65DC-BPi-11
CAS:DC-BPi-11 inhibits BPTF at IC50 698 nM and significantly reduces leukemia cell growth.Formel:C20H23N5O2SFarbe und Form:SolidMolekulargewicht:397.49Chelidonine hydrochloride
CAS:Chelidonine hydrochloride is one of the alkaloids of Chelidonium majus, which has broad pharmacological activitiesFormel:C20H20ClNO5Reinheit:>99.99%Farbe und Form:SolidMolekulargewicht:389.83PDE5-IN-4
CAS:PDE5-IN-4, a phosphodiesterase 5 (PDE5) inhibitor, is utilized in research concerning acute myocardial infarction and reperfusion-related damage,Formel:C21H27N5O5SFarbe und Form:SolidMolekulargewicht:461.53NSD3-IN-1
CAS:NSD3-IN-1, a histone methyltransferase NSD3 inhibitor, demonstrates an IC50 of 28.58 μM.Formel:C13H13N5OSFarbe und Form:SolidMolekulargewicht:287.34NSD3-IN-2
CAS:NSD3-IN-2: Potent NSD3 inhibitor, IC50 17.97μM, halts NSCLC growth (H460, H1299, H1650) with anticancer effects.Formel:C17H15N5OSFarbe und Form:SolidMolekulargewicht:337.4NSD3-IN-3
CAS:"NSD3-IN-3, a potent anticancer agent, inhibits NSD3 (IC50: 1.86 μM) and hampers H460 lung cancer cell growth."Formel:C15H17N5O2SFarbe und Form:SolidMolekulargewicht:331.39AChE-IN-9
AChE-IN-9: Tacrine-β-glucose glycoconjugate; IC50 0.4μM; reduced hepatotoxicity; Alzheimer's research.Formel:C30H35N5O9Farbe und Form:SolidMolekulargewicht:609.63EZH2-IN-7
CAS:<p>EZH2-IN-7 inhibits EZH2, reducing H3K27me3 and tumor growth (e.g., breast, prostate cancer, leukemia). Potential in cancer research.</p>Formel:C31H37D2N5O3SFarbe und Form:SolidMolekulargewicht:563.75PIM1-IN-4
CAS:<p>PIM1-IN-4: strong PIM1 inhibitor, also blocks SGK-1, PKA, CaMK-1, GSK3β, MSK1; promising for cancer studies.</p>Formel:C27H25BrCl2CuN6OReinheit:98%Farbe und Form:SolidMolekulargewicht:663.88RET-IN-13
CAS:RET-IN-13: potent quinoline RET inhibitor; IC50 = 0.5 nM (WT), 0.9 nM (V804M); potential for RET-related tumor/intestinal disease research.Formel:C32H33F4N5O3Farbe und Form:SolidMolekulargewicht:611.63HBV-IN-15
CAS:HBV-IN-15, a flavone derivative, is a potent cccDNA inhibitor, potentially aiding HBV research.Formel:C24H23ClO6Farbe und Form:SolidMolekulargewicht:442.89JAK-IN-17
"JAK-IN-17: Potent JAK inhibitor for studying ocular, skin, and respiratory diseases."Formel:C33H38F2N6O8Farbe und Form:SolidMolekulargewicht:684.69EIDD-2749
CAS:<p>EIDD-2749 (4'-Fluorouridine), an oral drug, inhibits RdRp, halts RSV/SARS-CoV-2 replication, and fights HCV/LCMV.</p>Formel:C9H11FN2O6Reinheit:97.39%Farbe und Form:SolidMolekulargewicht:262.19TrxR-IN-4
CAS:TrxR-IN-4, a strong TrxR inhibitor, induces ERS, apoptosis in HepG2 cells, reduces liver damage by lowering TrxR and inflammation.Formel:C28H20AuF8N2O2PFarbe und Form:SolidMolekulargewicht:796.4Akt1-IN-1
Akt1-IN-1: Potent, selective Akt1 inhibitor, IC50 18.79 nM, non-teratogenic/hepatotoxic/cardiotoxic, useful in cancer research.Formel:C31H34FN5O5S2Farbe und Form:SolidMolekulargewicht:639.76RET-IN-16
CAS:RET-IN-16: Selective RET inhibitor, IC50s 3.98-15.05 nM for various RET mutations; anticancer properties.Formel:C31H29F3N8O2Farbe und Form:SolidMolekulargewicht:602.61USP7-IN-9
USP7-IN-9 is a potent USP7 inhibitor (IC50 = 40.8 nM), induces apoptosis, arrests RS4;11 cells, and modulates key oncoproteins.Formel:C32H33ClF6N6O8Farbe und Form:SolidMolekulargewicht:779.086H05 (TFA)
CAS:6H05 TFA (6H05 trifluoroacetate) is a selective, and allosteric oncogenic mutant K-Ras(G12C) inhibitor.Formel:C22H31ClF3N3O4S3Reinheit:98.83%Farbe und Form:SolidMolekulargewicht:590.14C5aR-IN-1
CAS:C5aR-IN-1, a potent C5aR inhibitor, may aid in researching autoimmune and inflammatory diseases.Formel:C36H39F4N3O2Farbe und Form:SolidMolekulargewicht:621.71C5aR-IN-3
CAS:C5aR-IN-3, a potent C5aR inhibitor, may treat autoimmune and inflammatory diseases.Formel:C36H40FN5O3Farbe und Form:SolidMolekulargewicht:609.73L2H2-6OTD
CAS:L2H2-6OTD is a telomerase inhibitor with G-quadruplex loops; IC50: 15 nM.Formel:C30H30N10O8Farbe und Form:SolidMolekulargewicht:658.62Tolindate
CAS:Tolindate, a potent PXR agonist, demonstrates antifungal activity and possesses an EC50 value of 8.3 µM.Formel:C18H19NOSFarbe und Form:SolidMolekulargewicht:297.41NVS-MALT1
CAS:<p>NVS-MALT1 is an allosteric inhibitor of MALT1 [1].</p>Formel:C24H27ClF3N5O4SFarbe und Form:SolidMolekulargewicht:574.02VU6036720
<p>VU6036720 is a potent and selective inhibitor of the isomeric Kir4.1/5.1.VU6036720 inhibits Kir4.1/5.1 activity by decreasing the channel open-circuit</p>Formel:C20H22ClFN4O2SReinheit:98.1%Farbe und Form:SoildMolekulargewicht:436.93hRSV-IN-1
CAS:<p>hRSV-IN-1 is an inhibitor of respiratory syncytial virus (hRSV) .</p>Formel:C24H25N5O3SFarbe und Form:SolidMolekulargewicht:463.55
